ArticleBlood2018

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.

Rizwan Romee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.